KR20010099460A - Cholesterol stones in bile ducts using herbal ingredients - Google Patents

Cholesterol stones in bile ducts using herbal ingredients Download PDF

Info

Publication number
KR20010099460A
KR20010099460A KR1020010061088A KR20010061088A KR20010099460A KR 20010099460 A KR20010099460 A KR 20010099460A KR 1020010061088 A KR1020010061088 A KR 1020010061088A KR 20010061088 A KR20010061088 A KR 20010061088A KR 20010099460 A KR20010099460 A KR 20010099460A
Authority
KR
South Korea
Prior art keywords
bile
product
liver
cholesterol
stones
Prior art date
Application number
KR1020010061088A
Other languages
Korean (ko)
Inventor
서석춘
박성구
Original Assignee
서석춘
박성구
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서석춘, 박성구 filed Critical 서석춘
Priority to KR1020010061088A priority Critical patent/KR20010099460A/en
Publication of KR20010099460A publication Critical patent/KR20010099460A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 포도씨유, 올리브유, 식용유, 비타민 C, 구연산 등을 구성요소로 제조한 제품ⓟ와 결명자, 황정, 당귀, 마그네슘 설페이트 등을 구성요소로 제조한 제품ⓢ을 섭취시 첫째, 담즙의 배출을 조절하는 콜레시스토키닌(cholecytoinin) 호르몬을 자극하여 담낭을 이완시키며, 오디 괄약근의 저항력을 감소시켜 담즙의 간 분비를 증가시킨다. 이로 인하여 담도의 내용물이 십이지장으로의 유출을 증대시킨다. 둘째, 담즙은 간에서 생산되며 간내에 있는 여분의 콜레스테롤이 핵을 이루어 핵 주위에 이물질이 모여 결석을 만들며, 이를 콜레스테롤 결석이라 하는데 제품ⓢ를 섭취하면 담관(간내, 간외)이 느슨하게 이완됨을 도와 장내에 있던 변이 체외로 배설되고, 마지막으로 장내에 이미 배출되어 있던 콜레스테롤 결석이 체외로 배설되어 물에 떠 있는 것을 육안으로 관찰할 수 있다. 따라서 본 발명 제품ⓟ와 제품ⓢ는 담즙대사를 원활하게 도와주며, 담석으로 인한 질환(간경변, 비만, 회장질환, 용혈, 단도폐쇄, 폐색성 황달 등)에 대하여 효과적으로 유용 될 수 있다.The present invention is a product prepared with grape seed oil, olive oil, edible oil, vitamin C, citric acid and the like ⓟ and product ⓢ prepared by the component, namely, yellow, sugar, magnesium sulfate, etc. First, the discharge of bile Stimulates the cholecytoinin hormone that regulates, relaxes the gallbladder and decreases the resistance of the Audi sphincter to increase bile liver secretion. This increases the outflow of the contents of the biliary tract into the duodenum. Second, bile is produced in the liver, and extra cholesterol in the liver forms a nucleus, and foreign substances gather around the nucleus to form stones, which are called cholesterol stones. When the product ⓢ is ingested, the bile ducts (liver and extrahepatic) are loosened, helping the intestines to relax. The feces in the body are excreted in vitro, and finally, the cholesterol stones that have already been excreted in the intestine can be excreted in vitro and floated in the water. Therefore, the product ⓟ and the product ⓢ of the present invention helps bile metabolism smoothly, it can be effectively useful for diseases caused by gallstones (cirrhosis, obesity, ileal disease, hemolysis, stiletto obstruction, obstructive jaundice, etc.).

Description

한방 원료를 이용한 담관내 콜레스테롤 결석 제거방법{omitted}Removal method of cholesterol stones in bile ducts using herbal ingredients {omitted}

담관을 막아서 담즙의 흐름을 방해하는 간내 콜레스테롤 담석을 배출함으로써 담즙대사를 원활히 하고, 담석으로 인한 질환을 사전에 예방하여 건강한 삶을 영위하기 위함이다.By blocking the bile ducts and discharging intrahepatic cholesterol gallstones that interfere with the flow of bile to facilitate bile metabolism, and to prevent diseases caused by gallstones in order to lead a healthy life.

본 발명은 한방 원료를 이용한 담석배출에 관한 것으로서, 더욱 상세하게는 포도씨유, 올리브유, 식용유, 비타민 C, 구연산 등을 구성요소로 제조한 제품ⓟ와 결명자, 황정, 당귀, 마그네슘 설페이트 등을 구성요소로 제조한 제품ⓢ을 섭취하여 담관을 막아서 담즙의 흐름을 방해하는 간내 담석을 배출하는 제품 및 방법에 관한 것이다.The present invention relates to a stone discharge using a shot material, and more particularly, to configuring the grape seed oil, olive oil, vegetable oil, vitamin C, manufactured by the component citric acid product ⓟ and Cassia tora, hwangjeong, Angelica, magnesium sulfate, etc. urea The present invention relates to a product and a method for releasing intrahepatic gallstones by blocking the bile ducts by ingesting the product ⓢ prepared as.

담석의 제거방법은 외과적으로 개복을 해서 담낭을 절재하는 방법, 결석 용해제를 경구적으로 복용시키는 방법, 개복하지 않고 내시경을 사용하여 유두괄약근절개술로 결석을 제거하는 방법 등 매우 다양하다.There are many ways to remove gallstones such as surgically open ablation of the gallbladder, oral administration of calcite lysates, and removal of stones by papillary sphinctomy with an endoscope without an open abdomen.

그러나, 이 방법들은 담낭 담석이나 총 담관 담석을 제거하는 것일 뿐, 간 속에 생긴 담석을 제거할 수 없다.However, these methods only remove gallstones or gallstones and cannot remove gallstones in the liver.

간내 담석은 적 개는 수십 개부터 많게는 이천 개의 담석이 간 속 깊이 광범위하게 박혀 있는데, 이것은 간을 절개할 수도 없고, 담도경을 삽입해서 한 달에 걸쳐 일일이 깨낸다는 것은 극히 어려운 작업이기 때문이다. 또한 담도경을 통해 담석 용해제를 간 속으로 주입하여 담석을 녹인 다음 담도경으로 끄집어내는 시술방법 역시 적어도 20일의 입원과 수술이 필요하므로 많은 비용과 시간이 소요되며, 모세담관이나 세담관과 같이 직경이 가는 담관속의 담석도 담도경을 통해 제거할 수 있을지는 여전히 의문이다. 간내 담석은 진단하기도 어렵고, 배출하기도 매우 어려운 실정이며, 간내 담석은 담즙의 흐름을 방해하여 결국은 간 기능의 저하를 가져와 다음과 같은 문제점들을 일으킬 수 있다.Intrahepatic gallstones are embedded in dozens or as many as two thousand gallstones deep into the liver, because it is not possible to cut the liver, and it is extremely difficult to insert a bile duct in one month. In addition, the method of injecting a gallstone dissolving agent into the liver through the biliary tract dissolves the gallstones and then draws them into the biliary tract, requiring at least 20 days of hospitalization and surgery, which is expensive and time consuming. It is still doubtful whether gallstones in the bile duct can be removed through the bile duct. Hepatic gallstones are difficult to diagnose and very difficult to discharge, and hepatic gallstones can disrupt the flow of bile and eventually lead to deterioration of liver function, resulting in the following problems.

1) 담즙의 울체로 인한 폐색성 황달, 담즙성 간경화 초래1) obstructive jaundice due to biliary ulcers, causing biliary cirrhosis

2) 담즙의 생성부진으로 콜레스테롤·어혈이 쌓여 각종 질병의 원인을 제공2) Cholesterol and fish blood accumulate due to poor production of bile, which causes various diseases

3) 간의 해독작용을 비롯한 제기능의 저하로 항상 피곤하다.3) deterioration of the liver, including detoxification function is always tired.

4) 지방의 소화가 제대로 안되고 대변에서 심한 냄새가 난다.4) Fat is not digested properly and there is a bad smell in the stool.

5) 체내 독소가 배출되지 못하고 몸 안에 쌓이거나 피부로 나와서 알레르기를 일으킨다.5) Toxins in the body cannot be discharged and accumulated in the body or come out of the skin causing allergies.

6) 담석이 췌관 입구를 막으면 당뇨를 유발한다.6) When gallstones block the opening of the pancreatic duct, it causes diabetes.

위와 같은 문제들을 해결할 수 있는 간내 담석배출용 제품 개발이 필요하다.It is necessary to develop a product for intrahepatic gallstone discharge that can solve the above problems.

상기 문제점들을 해결하기 위하여 본 발명의 목적은 상기 담석의 제거방법들과는 전혀 다른 방법으로서 한방 원료를 이용한 간내 담석배출 제품으로써 경구적인 방법으로 저비용·단시간에 효험을 직접 확인 할 수 있으며, 담즙대사를 원활히 해주므로써 담석으로 인한 질환을 사전에 예방할 수 있다.In order to solve the above problems, an object of the present invention is a method completely different from the removal method of the gallstones as an intrahepatic gallstone discharge product using herbal raw materials can be directly confirmed the efficacy in low cost, short time by oral method, and smooth bile metabolism By doing so, you can prevent diseases caused by gallstones in advance.

즉, 본 발명은 포도씨유, 올리브유, 식용유, 비타민 C, 구연산 등을 구성요소로 제조한 제품ⓟ와 결명자, 황정, 당귀, 마그네슘 설페이트 등을 구성요소로 제조한 제품ⓢ을 경구적으로 2-3회 섭취시 답즙의 배출을 조절하는 콜레시스토키닌 호르몬 자극 및 단관(간내·간외)이 느슨하게 이완됨으로 간내 담석을 배출해주며 담즙대사를 원활히 해주어 간에 제 기능을 회복해 주는 역할로 경구용 간내 담석 배출용 제품을 제공하는 것이다.That is, the present invention is 2 to 3 in the product produced ⓢ the grape seed oil, olive oil, vegetable oil, vitamin C, the product ⓟ made of the components such as citric acid and Cassia tora, hwangjeong, Angelica, magnesium sulfate, etc. as a component orally Cholecystokinin hormone stimulation that regulates the release of bile during ingestion and loosen the canal (intrahepatic and extrahepatic) loosen the liver, release gallstones and facilitate the bile metabolism to restore the function of the liver oral hepatic gallstone discharge products To provide.

본 구성요소로 제조한 제품ⓟ와 제품ⓢ를 실시 예와 같이 복용함으로서 담관내 콜레스테롤 결석이 체외로 배출됨을 확인 할 수 있다.By taking the product ⓟ and product ⓢ prepared with this component as in the embodiment it can be confirmed that cholesterol stones in the bile ducts are discharged in vitro.

이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 포도씨유, 올리브유,식용유, 비타민 C, 구연산 등을 구성요소로 제조한 제품ⓟ는 지방과 아미노산이 주성분으로 담낭에서 담즙의 배출을 조절하는 콜레시토키닌 호르몬은 지방과 아미노산 섭취에 반응을 촉진하게 된다. 콜레시스토키닌 호르몬은 담낭의 강력한 수축을 일으키며, 오디 괄약근의 저항력을 감소시켜 담즙의 간 분비를 증가시킨다. 이로 인하여 담도의 내용물이 십이지장으로 유출을 증대시킨다. 담즙은 간에서 생성되며 간내에 있는 여분의 콜레스테롤이 핵을 이루어 핵 주위에 이물질이 모여 결석을 만드는데 이를 콜레스테롤 결석이라 한다. 이 담석이 담관(간내·간외)에 존재하면 담즙대사에 장애를 일으켜 담석으로 인한 질환(간경변, 비만, 회장질환, 용혈, 단도폐쇄, 폐색성 황달 등)을 초래하게 된다.The present invention is a product prepared from grape seed oil, olive oil, cooking oil, vitamin C, citric acid and the like ⓟ is the main component of the fat and amino acid cholecytokine hormone that regulates the release of bile from the gallbladder promotes the reaction to fat and amino acid intake Done. Cholecystokinin hormone causes strong contraction of the gallbladder and decreases the resistance of the auditory sphincter to increase bile liver secretion. This increases the outflow of the contents of the biliary tract into the duodenum. Bile is produced in the liver, and extra cholesterol in the liver forms a nucleus, and foreign matter gathers around the nucleus to form stones, which are called cholesterol stones. The presence of gallstones in the bile ducts (intrahepatic and extrahepatic) can cause bile metabolism, resulting in diseases caused by gallstones (liver cirrhosis, obesity, ileal disease, hemolysis, stiletto obstruction, obstructive jaundice).

본 발명에 있어서 결명자, 황정, 당귀, 마그네슘 설페이트 등을 구성요소로 제조한 제품ⓢ을 섭취하면 담관(간내·간외)이 느슨하게 이완되어 장내에 있는 변이 1차 배출되고, 장내에 이미 배출되어 있던 콜레스테롤 결석이 체외로 배설되어 물에 등등 떠 있는 것을 관찰할 수 있다.In the present invention, when ingestion of the product ⓢ , which is composed of clarifiers, yellow eyes, donkeys, magnesium sulfate, and the like, the bile ducts (liver and extrahepatic) are loosened and the stool in the intestine is first discharged, and the cholesterol already discharged in the intestine You can observe the stones excreted in vitro and floating in the water.

실시예Example

1) 점심식사 후 오후 2시경부터는 아무것도 드시지 마십시오1) Do not eat anything from around 2pm after lunch

2) 오후 6시, 8시에 콜바란스 제품ⓢ각 2봉지씩 잘 흔들어 드십시오2) Shake each bag at 6 pm and 8 pm with kol balance products ⓢ

3) 오후10시 콜바란스 제품ⓟ의 남은 공간에 오렌지 쥬스를 거의 채워 드십시오. 이때 머리를 높게하여 30분 정도 움직이지 말고 편히 계십시오3) Fill the remaining space of the Colvarance product ⓟ at 10 pm and fill up the orange juice. Keep your head high and do not move for about 30 minutes.

4) 다음 날 오전 6시 콜바란스 제품ⓢ2봉지씩 잘 흔들어 드십시오4) Shake two bags of Cobalanse products ⓢ the next day at 6 am

5) 오전 8시 콜바란스 제품ⓢ2봉지씩 잘 흔들어 드신 후 바로 오후 10시에서의 드시는 방법과 같이 콜바란스 제품ⓟ남은 공간에 오렌지 쥬스를 거의 채워드십시오. 이때 머리를 높게하여 30분 정도 움직이지 말고 편히 계십시오5) Call 8:00 a.m. balanced product ⓢ 2 bags to shake a little less orange juice products ⓟ call balance remaining space as you enjoy how at 10:00 pm just after the word deusin by. Keep your head high and do not move for about 30 minutes.

상기 실시예 및 도 1a를 통하여 확인된 바와 같이 본 발명의 제품을 사용한 경우에는 폐색성 황달, 답즙성 간 경화로부터 보호, 콜레스테롤의 처리 및 지방간 해소, 간의 해독작용 등 제 기능의 회복, 지방소화촉진, 담이 결리고 뒷목이 항상 뻐근하던 증상 해소, 독소로 인한 알레르기 감소효과, 숙변제거 등의 효과를 가져올 수 있다. 또한 본 제품은 병원에 장기간 입원하거나 수술을 하는 등 많은 비용과 시간을 들이지 않고도 누구나 간편하게 복용할 수 있는 장점이 있고 가정에서 본인이 직접 실시할 수 있으므로 비용측면에서 대단히 경제적이다.In the case of using the product of the present invention, as confirmed through the above Examples and Figure 1a, the blockade of jaundice, protection from cholestatic liver hardening, cholesterol treatment and fatty liver relief, liver detoxification, recovery of functions such as liver, promotes digestion of fat In addition, the phlegm is stiff and the back neck is always relieved of symptoms, toxin allergies due to the effect of reducing stool can have the effect. In addition, this product has the advantage that anyone can take it easily without spending a lot of money and time, such as long-term hospitalization or surgery, and it is very economical in terms of cost because it can be performed by yourself at home.

Claims (2)

포도씨유, 올리브유, 식용유, 비타민 C, 구연산 등을 구성요소로 제조한 제품ⓟ와 결명자, 황정, 당귀, 마그네슘 설페이트 등을 구성요소로 제조한 제품ⓢ으로써 담관(간내·간외)내 콜레스테롤 결석 배출방법Bile duct as grape seed oil, olive oil, vegetable oil, products ⓢ preparing a vitamin C, manufactured by the component citric acid product ⓟ and Cassia tora, hwangjeong, Angelica, magnesium sulfate, etc. as a component (intrahepatic, extrahepatic) method cholesterol away from the discharge 포도씨유, 올리브유, 식용유, 비타민 C, 구연산 등을 구성요소로 제조한 제품ⓟ와 결명자, 황정, 당귀, 마그네슘 설페이트 등을 구성요소로 제조한 제품ⓢ으로써 담석 배출용 기능성 식·의약품 제조방법Grape seed oil, olive oil method, vegetable oil, vitamin C, citric acid, such as a component of products ⓟ and Cassia tora, hwangjeong, Angelica, such as magnesium sulfate as a product made of components ⓢ discharged functional food and medicine manufacturing stones made of a
KR1020010061088A 2001-09-29 2001-09-29 Cholesterol stones in bile ducts using herbal ingredients KR20010099460A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010061088A KR20010099460A (en) 2001-09-29 2001-09-29 Cholesterol stones in bile ducts using herbal ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010061088A KR20010099460A (en) 2001-09-29 2001-09-29 Cholesterol stones in bile ducts using herbal ingredients

Publications (1)

Publication Number Publication Date
KR20010099460A true KR20010099460A (en) 2001-11-09

Family

ID=19714865

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010061088A KR20010099460A (en) 2001-09-29 2001-09-29 Cholesterol stones in bile ducts using herbal ingredients

Country Status (1)

Country Link
KR (1) KR20010099460A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040003916A (en) * 2002-07-04 2004-01-13 신흥철 Drink Composition Having Removal Efficacy of Gallstone
CN116549427A (en) * 2023-05-26 2023-08-08 时珍本草生物科技(中山)有限公司 New use of hydroxycitric acid for treating cholelithiasis and cholecystitis induced by cholelithiasis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000072005A (en) * 2000-06-20 2000-12-05 남봉길 The method of preparing for urinary calculus lithiasis for reatment(crystal type)
KR20010027403A (en) * 1999-09-13 2001-04-06 민병길 The method of preparing for urinary calculus lithiasis for treatment
KR20010044676A (en) * 2001-03-15 2001-06-05 김형식 Compositions for cleaning the liver
KR20020074260A (en) * 2001-03-19 2002-09-30 박기만 Compositions for excluding waste materials from the body comprising grapefruit juice, Schizandrae Fructus extract and olive oil

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010027403A (en) * 1999-09-13 2001-04-06 민병길 The method of preparing for urinary calculus lithiasis for treatment
KR20000072005A (en) * 2000-06-20 2000-12-05 남봉길 The method of preparing for urinary calculus lithiasis for reatment(crystal type)
KR20010044676A (en) * 2001-03-15 2001-06-05 김형식 Compositions for cleaning the liver
KR20020074260A (en) * 2001-03-19 2002-09-30 박기만 Compositions for excluding waste materials from the body comprising grapefruit juice, Schizandrae Fructus extract and olive oil

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040003916A (en) * 2002-07-04 2004-01-13 신흥철 Drink Composition Having Removal Efficacy of Gallstone
CN116549427A (en) * 2023-05-26 2023-08-08 时珍本草生物科技(中山)有限公司 New use of hydroxycitric acid for treating cholelithiasis and cholecystitis induced by cholelithiasis
CN116549427B (en) * 2023-05-26 2024-01-26 时珍本草生物科技(中山)有限公司 Application of hydroxycitric acid lactone in preparation of medicine for treating gall-stone

Similar Documents

Publication Publication Date Title
CN103068326B (en) The apparatus and method for treating gallstone disease
CN101554462B (en) Medicament for curing cancer
CN104585672B (en) A kind of feature Rhizoma Dioscoreae esculentae mud and preparation method
US20030044512A1 (en) Liver function improvement formulation
Micucci et al. Hibiscus Sabdariffa L. flowers and Olea Europea L. leaves extract-based formulation for hypertension care: In vitro efficacy and toxicological profile
CN107660795A (en) One kind prevention gout plaster taste and preparation method thereof
KR101725912B1 (en) The Pharmaceutical composition for the prevention and treatment of diabetic complications and angioedema comprising natural mixture extracts
Kulshreshtha et al. Pathophysiological status and nutritional therapy of peptic ulcer: An update
Liangpunsakul et al. Treatment of nonalcoholic fatty liver disease
KR20010099460A (en) Cholesterol stones in bile ducts using herbal ingredients
Kushner Obesity management
Schöffl et al. Intestinal obstruction due to phytobezoars of banana seeds: a case report
Brückner et al. Endoscopic treatment of a pancreatic abscess originating from biliary pancreatitis
CN102670849A (en) Anal fistula suppository
KR100536163B1 (en) Compositions for the prevention or treatment of cancer
RU2214240C1 (en) Method for treatment of patients with psoriasis in combination with chronic opisthorchiasis
RU2411955C1 (en) Medication for treating intestinal dysbiosis in patients with chronic cryptogenic hepatitis
Akcakaya Phytotherapy in Obesity: Is It Necessary to Have Surgery?
Gersin Endoscopic Liners (Duodenojejunal Bypass Liner, Gastroduodenojejunal Bypass Sleeve)
RU2519198C2 (en) Method of treating patients suffering from first stage cholelithiasis
CN104758708A (en) Medicine for treating diarrhea
WO2012125013A1 (en) Herbal polypharmaceutical for preventing and treating atherosclerosis
Patnaik Breakthrough Anti-Ageing Cure
CN112022999A (en) Traditional Chinese medicine composition for treating liver and gall stone, and preparation method and application thereof
KR101350593B1 (en) Method for manufacturing combined preparations containing saw palmetto and zinc sulfate

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
E601 Decision to refuse application